DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Hardman Johnston Global Advisors LLC

Hardman Johnston Global Advisors LLC decreased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 7.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 622,798 shares of the medical instruments supplier's stock after selling 52,539 shares during the quarter. Hardman Johnston Global Advisors LLC owned about 0.29% of DENTSPLY SIRONA worth $22,165,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. International Assets Investment Management LLC acquired a new stake in DENTSPLY SIRONA in the fourth quarter worth about $782,000. Cambiar Investors LLC lifted its holdings in DENTSPLY SIRONA by 15.2% in the fourth quarter. Cambiar Investors LLC now owns 323,432 shares of the medical instruments supplier's stock worth $11,511,000 after purchasing an additional 42,685 shares during the period. Nisa Investment Advisors LLC lifted its holdings in DENTSPLY SIRONA by 3.5% in the fourth quarter. Nisa Investment Advisors LLC now owns 36,779 shares of the medical instruments supplier's stock worth $1,309,000 after purchasing an additional 1,242 shares during the period. Arvest Trust Co. N A acquired a new stake in DENTSPLY SIRONA in the fourth quarter worth about $237,000. Finally, Arizona State Retirement System lifted its holdings in DENTSPLY SIRONA by 2.1% in the fourth quarter. Arizona State Retirement System now owns 59,184 shares of the medical instruments supplier's stock worth $2,106,000 after purchasing an additional 1,215 shares during the period. Institutional investors and hedge funds own 95.70% of the company's stock.

Analyst Upgrades and Downgrades


Several research firms recently weighed in on XRAY. Needham & Company LLC reaffirmed a "buy" rating and issued a $42.00 price objective on shares of DENTSPLY SIRONA in a report on Thursday, February 29th. SVB Leerink initiated coverage on shares of DENTSPLY SIRONA in a report on Monday, February 26th. They issued an "outperform" rating and a $42.00 price target for the company. StockNews.com raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday, January 19th. Piper Sandler upped their price target on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a "neutral" rating in a report on Friday, January 12th. Finally, Leerink Partnrs reissued an "outperform" rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $39.50.

Read Our Latest Report on DENTSPLY SIRONA

DENTSPLY SIRONA Trading Down 2.2 %

NASDAQ XRAY traded down $0.72 on Friday, hitting $31.30. 3,000,870 shares of the company were exchanged, compared to its average volume of 3,481,979. The company's 50 day moving average price is $33.08 and its 200-day moving average price is $32.97. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95. The firm has a market capitalization of $6.49 billion, a P/E ratio of -50.48, a price-to-earnings-growth ratio of 1.31 and a beta of 0.98. DENTSPLY SIRONA Inc. has a twelve month low of $26.27 and a twelve month high of $43.24.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.01. The firm had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $972.61 million. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The business's revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.46 EPS. Analysts predict that DENTSPLY SIRONA Inc. will post 2.05 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 12th. Stockholders of record on Friday, March 29th will be issued a $0.16 dividend. This is an increase from DENTSPLY SIRONA's previous quarterly dividend of $0.14. The ex-dividend date is Wednesday, March 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.04%. DENTSPLY SIRONA's dividend payout ratio is currently -103.22%.

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in DENTSPLY SIRONA right now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Featured Articles and Offers

Search Headlines: